Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Manufacturing Operations: SOP for Sterile Handling of Ampoules during Manufacturing – V 2.0

Posted on By

Manufacturing Operations: SOP for Sterile Handling of Ampoules during Manufacturing – V 2.0

Standard Operating Procedure for Sterile Handling of Ampoules during Manufacturing


Department Manufacturing Operations
SOP No. SOP/MO/124/2025
Supersedes SOP/MO/124/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define the standard procedures for the sterile handling of ampoules during manufacturing of sterile injectable products, ensuring compliance with cGMP and minimizing the risk of contamination.

2. Scope

This SOP applies to all ampoules used for filling of injectable formulations in sterile areas, including processes

such as unloading, washing, sterilization, handling, and transfer within the sterile manufacturing facility.

3. Responsibilities

  • Manufacturing Personnel: Handle ampoules aseptically and perform tasks as per defined protocols.
  • Engineering Department: Maintain equipment such as ampoule washing machines, sterilizers, and conveyors.
  • Quality Assurance: Monitor compliance with SOP and perform line clearances.
  • Quality Control: Conduct in-process checks on ampoule quality and cleanliness.
See also  In-Process Control: SOP for Ensuring Accuracy of In-Process Weight Checks - V 2.0

4. Accountability

The Head of Manufacturing is accountable for ensuring sterile handling practices are followed for ampoules. The QA Head is accountable for ensuring regulatory and procedural compliance.

5. Procedure

5.1 Receipt and Unloading of Ampoules

  1. Receive ampoules in sealed corrugated boxes or shrink-wrapped trays from approved suppliers.
  2. Check for integrity of packaging, supplier label, and quantity as per invoice.
  3. Record details in the Ampoule Receipt Logbook (Annexure-1).

5.2 Visual Inspection of Ampoules

  1. Visually inspect ampoules for any defects like cracks, chips, or foreign particles.
  2. Segregate and document any defective ampoules.

5.3 Washing of Ampoules

  1. Load ampoules into the washing machine trays with necks facing upward.
  2. Use a validated multijet ampoule washing machine.
  3. Run the ampoule washing cycle with WFI (Water for Injection) and compressed filtered air.
  4. Final rinse must be with WFI and drained appropriately.
  5. Record the washing activity in the Ampoule Washing Log (Annexure-2).

5.4 Sterilization and Depyrogenation

  1. Transfer washed ampoules to tunnel sterilizer under unidirectional airflow.
  2. Sterilize ampoules at validated parameters (e.g., 300°C for 30 minutes).
  3. Cool and transfer sterile ampoules directly into aseptic area via sterile conveyor.
  4. Do not manually touch ampoules post-sterilization.
See also  Sterile Injectable Manufacturing: SOP for Reconciliation of Materials Used in Manufacturing - V 2.0

5.5 Handling during Filling

  1. Ensure ampoules remain under laminar airflow during loading into filling equipment.
  2. Do not use any ampoule found damaged, discolored, or deformed.
  3. Only use ampoules within the validated hold time post-sterilization.

5.6 Post-Filling Transfer

  1. Transfer ampoules for sealing and visual inspection via sterile conveyor.
  2. Avoid accumulation of ampoules during transfer to prevent breakage.

5.7 Documentation

  1. Record all details in the respective logbooks such as:
    • Ampoule Receipt Log
    • Ampoule Washing Log
    • Sterilization Record
    • Filling Batch Record

6. Abbreviations

  • SOP: Standard Operating Procedure
  • WFI: Water for Injection
  • QA: Quality Assurance
  • QC: Quality Control
  • cGMP: current Good Manufacturing Practices

7. Documents

  1. Ampoule Receipt Log – Annexure-1
  2. Ampoule Washing Log – Annexure-2
  3. Sterilization Record – Annexure-3
  4. Filling Batch Record – Annexure-4

8. References

  • WHO TRS 961 – Annex 6: GMP for Sterile Products
  • EU GMP Guidelines – Annex 1
  • ISO 14644 – Cleanroom Standards
See also  Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intradermal Injections - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Ampoule Receipt Log

Date Supplier Lot No. Qty Received Inspected By Remarks
20/06/2025 Vimal Glass VL-AMP-205 50,000 Sunita Reddy OK

Annexure-2: Ampoule Washing Log

Date Batch No. Washer ID Cycle Start End Time Operator Remarks
21/06/2025 AMP/IV/240 WASH-03 09:00 AM 09:45 AM Rakesh Yadav Normal

Annexure-3: Sterilization Record

Date Batch No. Tunnel ID Temperature Hold Time Operator QA Verified
21/06/2025 AMP/IV/240 TUN-02 300°C 30 min Rakesh Yadav Yes

Annexure-4: Filling Batch Record

Batch No. Filling Start Filling End Filler ID Qty Filled Operator Remarks
AMP/IV/240 10:30 AM 12:45 PM FILL-04 48,000 Mahesh Patel OK

Revision History

Revision Date Revision No. Details Reason Approved By
10/07/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Enhanced steps for washing and conveyor transfer Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: CAPA Risk: Closing Without SOP Revisions
Next Post: Elixir Department: SOP for Preventive Maintenance of Filling Machines – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version